Tonsils – the brain’s drain

Globally, more than 50% of all people are infected [8], with the prevalence of escalating with age. [9]

Helicobacter Pylori is a gram-negative bacterium that colonises within the human gastrointestinal tract (this includes the mouth).

Symptoms:

• Belching
• Nausea
• Vomiting
• Difficulty swallowing
• Abdominal discomfort
• Upper abdominal bloating
• Decreased appetite
• Peptic ulcers
• Bad breath
• Heartburn
• Reoccurring oral plaque
• Gingivitis
• Tooth cavities

‍

Risks:

• H. Pylori infection is the main cause of chronic gastritis, with an infection rate between 80%-95% in sufferers. [7]
• It is present in almost all cases of duodenal ulcers and most cases of gastric ulcer [10] with as many as 90% of individuals with ulcers being infected.
• H. Pylori is a significant contributing factor for the risk of gastric cancers.
• H. Pylori burrows deep within parietal cells (cells that secrete stomach acid), not only does this make it harder to eradicate, but this also leads to unique symptoms within the host. One factor being hypochlorhydria (low levels of stomach acid secreted within the body); this prevents the host from sterilising bacteria in food, reduces the ability to obtain nutrients desired from food and the inability to assimilate certain key minerals, such as zinc or iron.
• Reduced intrinsic factor (IF) production is also likely for individuals suffering from a H. Pylori infection. IF is essential to bind with vitamin B12, preventing further breakdown from stomach acid along with attaching to the surface of the ileum to allow for absorption of B12 into the body.
• H. Pylori can also block vitamin C absorption, thus compounding to the amount of oxidative damage inflicted onto the body.
• H. Pylori infection augments the gastric mucosal damage induced by NSAIDs.
• H. Pylori antagonises Aspirin-induced delayed ulcer healing due to suppression of acid secretion by the enhancement of PGE2 possibly derived by COX2 expression.
• Benefits:
  Due to the nature of the parasite being a gram-negative bacteria, it shifts the immune system more towards a Th1 mediated response as opposed to Th2 – this can reduce the severity of allergies, asthma and other humeral/mucosal reactions.

‍

Benefits:

Due to the nature of the parasite being a gram-negative bacteria, it shifts the immune system more towards a Th1 mediated response as opposed to Th2 – this can reduce the severity of allergies, asthma and other humeral/mucosal reactions.

‍

References:

1. Morales-Espinosa R, et al., Oral Microbiol Immunol. 2009
2. Nguyen AM, et al., Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995
3. Miyabayashi H, et al., Helicobacter. 2000
4. Gebara EC, et al., J Clin Periodontol. 2006
5. Dye BA, et al., Am J Public Health. 2002
6. Eskandari A, et al. Med Oral Patol Oral Cir Bucal.
7. Abro AH, et al. J Ayub Med Coll Abbottabad. 2011
8. Saudi J Gastroenterol. 2014
9. J Gastrointestin Liver Dis. 2011
10. J Gastroenterol Hepatol. 2011
11. Surveillance of Helicobacter pylori antibiotic resistance in England and Wales; Public Health England, 2008
12. Jernberg, C, et al. 2010

Got plaque?

The conventional approach uses a process known as ‘Triple Therapy’ – this is the combination of two different antibiotics in-conjunction with a proton-pump inhibitor (which lowers HCL).

Not only does this have a low success rate, but it makes the host vulnerable to infection from other pathogens and parasites post-treatment. This is due to decreased stomach acid and a lessened ability to sterilise bacteria within food along with less competitive dominance within the gastrointestinal tract due to the eradication of the microbiota (pathogenic and beneficial species) within the gut, leaving available space to harbour unwanted bacteria.

H. Pylori is starting to develop resistance to antibiotics, making the conventional approach less and less effective – leading to the ‘thought’ process of adding more medication to the mix to overcome this resistance by using ‘Quadruple Therapy’.

The Health Protection Agency reports that the prevalence of H. Pylori antibiotic resistance varies within the UK depending on location, from 20-63% for metronidazole and 4.4-11% for clarithromycin. [11]

This is one factor explaining why as many as 20% of affected individuals have a reoccurring infection even after treatment.

Another factor for reinfection is the presence of H. Pylori in the oral cavity [1–3]; therefore, failure to eliminate H. Pylori from the mouth could lead to gastrointestinal reinfection.

Gingivitis and chronic periodontitis may be associated with H. Pylori infection and considered as a potential reservoir for bacteria. [4,5]

The plaque should be removed professionally, and oral hygiene procedures should be performed along with eradication strategies of H. Pylori [6] to increase the probability of success.

One could argue that an alternative approach yields much less risk to the host when compared with the iatrogenic complications and long-term hindrance from antibiotics (especially given that a single course of antibiotics can disturb the microbiome for unto 2-4 years post-treatment [12]).

The following has been found effective when addressing H. Pylori:

• Bismuth subcitrate
• Mastic gum
• Goldenseal/Berberine
• DGL Licorice wafers
• Matula tea

‍

The following foods have also been found beneficial:

• Coconut oil
• Manuka honey

‍

All this has to be addressed with the appreciation of humans being a multi-dimensional and bi-directional organism.

Seeking advice from a trusted professional is always recommended when dealing with any health ailments.

‍

References:

1. Morales-Espinosa R, et al., Oral Microbiol Immunol. 2009
2. Nguyen AM, et al., Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995
3. Miyabayashi H, et al., Helicobacter. 2000
4. Gebara EC, et al., J Clin Periodontol. 2006
5. Dye BA, et al., Am J Public Health. 2002
6. Eskandari A, et al. Med Oral Patol Oral Cir Bucal.
7. Abro AH, et al. J Ayub Med Coll Abbottabad. 2011
8. Saudi J Gastroenterol. 2014
9. J Gastrointestin Liver Dis. 2011
10. J Gastroenterol Hepatol. 2011
11. Surveillance of Helicobacter pylori antibiotic resistance in England and Wales; Public Health England, 2008
12. Jernberg, C, et al. 2010

Have you suffered challenges to your mental health?

Depression has the third highest burden of all diseases in Australia (13%) [1] and also third globally [2].

Almost half (45%) Australians will experience a mental illness in their lifetime [3].

One in five, about 20%, Australians aged 16-85 experience a mental illness in any year:

• 11.5% have one disorder and 8.5% have two or more disorders.
• 14% of Australians suffer from anxiety disorders.
• 6% depressive disorders [4].

The age with the highest prevalence of mental illness is between 18-24 years of age.

21.2% of adolescents between 15-19 years of age met the criteria for a probable serious mental illness [5].

Six Australians die from suicide every single day, with a further 30 people will attempt to take their own life [6].

Suicide is the leading cause of death for people Australians aged 25-44 and the second leading cause of death for young people aged 15-24 [7].

Australians are more likely to die by suicide than skin cancer.

Indigenous Australians experience double the rate of suicide when compared to non-indigenous Australians [8].

The LGBT community experiences four times the rate when compared with those identified as heterosexual [9].

In 2011, men accounted for 76% of deaths from suicide [10], yet an estimated 72% of males don’t seek help for mental disorders.

54% of sufferers with mental illness do not seek treatment [1], which is only compounded by the delay in treatment due to problems with detection, social stigma and accurate diagnosis.

Individuals with mental illness accessing treatment are half that of people seeking treatment with physical disorders [11].It’s time to raise awareness for mental health.

‍

References

1. Australian Institute of Health and Welfare. (2014). Australia’s Health 2014. AIHW: Canberra.
2. World Health Organisation. (2008). The global burden of disease: 2004 update.
3. Australian Bureau of Statistics. (2009). National Survey of Mental Health and Wellbeing: Summary of Results, 4326.0, 2007. ABS: Canberra.
4. Kitchener, B.A. and Jorm, A.F. (2009). Youth Mental Health First Aid: A manual for adults assisting youth. ORYGEN Research Centre, Melbourne.
5. Ivancic, L., Perrens, B., Fildes, J., Perry, Y. and Christensen, H. (2014). Youth Mental Health Report, June 2014. Mission Australia and Black Dog Institute, Sydney.
6. The Australian Senate. (2010). The Hidden Toll: Suicide in Australia Report of the Senate Community Affairs References Committee. Commonwealth of Australia, Canberra.
7. http://www.aihw.gov.au/deaths/causes-of- death
8. Australian Bureau of Statistic. (2012). Australian Health Survey: First Results. ABS, Canberra.
9. National Mental Health Commission. (2013). A Contributing Life, the 2013 National Report Card on Mental Health and Suicide Prevention. NMHC, Sydney.
10. Department of Health and Ageing. (2013). National Mental Health Report 2013: tracking progress of mental health reform in Australia 1993 – 2011. Commonwealth of Australia, Canberra.
11. Commonwealth of Australia. (2010). National Mental Health Report 2010. Canberra, Australia.